Structure

Physi-Chem Properties

Molecular Weight:  706.43
Volume:  738.304
LogP:  5.831
LogD:  4.83
LogS:  -5.134
# Rotatable Bonds:  20
TPSA:  151.73
# H-Bond Aceptor:  11
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.114
Synthetic Accessibility Score:  5.429
Fsp3:  0.821
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.779
MDCK Permeability:  6.305240822257474e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.808
Human Intestinal Absorption (HIA):  0.012
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.995

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.099
Plasma Protein Binding (PPB):  89.86885833740234%
Volume Distribution (VD):  0.714
Pgp-substrate:  2.6347861289978027%

ADMET: Metabolism

CYP1A2-inhibitor:  0.096
CYP1A2-substrate:  0.023
CYP2C19-inhibitor:  0.102
CYP2C19-substrate:  0.095
CYP2C9-inhibitor:  0.702
CYP2C9-substrate:  0.073
CYP2D6-inhibitor:  0.703
CYP2D6-substrate:  0.018
CYP3A4-inhibitor:  0.854
CYP3A4-substrate:  0.354

ADMET: Excretion

Clearance (CL):  10.749
Half-life (T1/2):  0.625

ADMET: Toxicity

hERG Blockers:  0.248
Human Hepatotoxicity (H-HT):  0.96
Drug-inuced Liver Injury (DILI):  0.85
AMES Toxicity:  0.006
Rat Oral Acute Toxicity:  0.106
Maximum Recommended Daily Dose:  0.014
Skin Sensitization:  0.253
Carcinogencity:  0.017
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.353

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC60295

Natural Product ID:  NPC60295
Common Name*:   AVICOTFUCGWABJ-UIOOFZCWSA-N
IUPAC Name:   n.a.
Synonyms:   (+)-2'-Norcocsuline
Standard InCHIKey:  AVICOTFUCGWABJ-UIOOFZCWSA-N
Standard InCHI:  InChI=1S/C34H32N2O5/c1-36-12-10-21-16-29-30-18-24(21)26(36)14-20-5-8-27(37)28(15-20)39-23-6-3-19(4-7-23)13-25-32-22(9-11-35-25)17-31(38-2)33(40-29)34(32)41-30/h3-8,15-18,25-26,35,37H,9-14H2,1-2H3/t25-,26-/m0/s1
SMILES:  COc1cc2CCN[C@@H]3c2c2c1Oc1cc4CCN([C@H](c4cc1O2)Cc1ccc(c(Oc2ccc(C3)cc2)c1)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL443331
PubChem CID:   44559018
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO24843 Pachygone dasycarpa Species Menispermaceae Eukaryota stem bark n.a. n.a. PMID[9157192]
NPO24843 Pachygone dasycarpa Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[9157192]
NPO24843 Pachygone dasycarpa Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens ED50 = 3800.0 nM PMID[572917]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 48.0 nM PMID[572917]
NPT2 Others Unspecified Selectivity Index = 79.0 n.a. PMID[572917]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 281.0 nM PMID[572917]
NPT2 Others Unspecified Selectivity Index = 14.0 n.a. PMID[572917]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC60295 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC191132
0.9941 High Similarity NPC11296
0.9941 High Similarity NPC274661
0.9941 High Similarity NPC82457
0.9941 High Similarity NPC48490
0.9941 High Similarity NPC175890
0.9706 High Similarity NPC167116
0.9706 High Similarity NPC274716
0.9706 High Similarity NPC254441
0.9655 High Similarity NPC256124
0.9647 High Similarity NPC290582
0.9647 High Similarity NPC54654
0.9647 High Similarity NPC181796
0.9647 High Similarity NPC279228
0.9647 High Similarity NPC311973
0.9647 High Similarity NPC8836
0.9647 High Similarity NPC258657
0.9647 High Similarity NPC7715
0.9647 High Similarity NPC229373
0.9647 High Similarity NPC251735
0.9647 High Similarity NPC182052
0.9647 High Similarity NPC239824
0.9647 High Similarity NPC290005
0.9647 High Similarity NPC104196
0.9647 High Similarity NPC285931
0.9647 High Similarity NPC222661
0.9647 High Similarity NPC223690
0.9647 High Similarity NPC217748
0.9647 High Similarity NPC49075
0.9647 High Similarity NPC90998
0.9647 High Similarity NPC42663
0.9647 High Similarity NPC328155
0.9647 High Similarity NPC185639
0.9647 High Similarity NPC15414
0.9647 High Similarity NPC271013
0.9588 High Similarity NPC239584
0.9588 High Similarity NPC286119
0.9532 High Similarity NPC30779
0.9529 High Similarity NPC243454
0.9529 High Similarity NPC475479
0.948 High Similarity NPC116465
0.948 High Similarity NPC212237
0.9425 High Similarity NPC22115
0.9425 High Similarity NPC275680
0.9371 High Similarity NPC206900
0.9368 High Similarity NPC139783
0.9368 High Similarity NPC65312
0.931 High Similarity NPC302245
0.931 High Similarity NPC95426
0.931 High Similarity NPC16357
0.9294 High Similarity NPC12424
0.9294 High Similarity NPC251580
0.9294 High Similarity NPC129518
0.9294 High Similarity NPC41376
0.9266 High Similarity NPC24260
0.9235 High Similarity NPC475215
0.9235 High Similarity NPC227060
0.9235 High Similarity NPC317439
0.9235 High Similarity NPC115284
0.9235 High Similarity NPC63646
0.9235 High Similarity NPC10908
0.9235 High Similarity NPC317145
0.9235 High Similarity NPC198498
0.9235 High Similarity NPC108434
0.9235 High Similarity NPC76682
0.9235 High Similarity NPC276890
0.9157 High Similarity NPC478093
0.9153 High Similarity NPC281581
0.9106 High Similarity NPC473589
0.9106 High Similarity NPC30182
0.9106 High Similarity NPC478092
0.9106 High Similarity NPC478091
0.9075 High Similarity NPC293093
0.9 High Similarity NPC240841
0.9 High Similarity NPC268503
0.9 High Similarity NPC317272
0.9 High Similarity NPC85381
0.9 High Similarity NPC256012
0.9 High Similarity NPC13916
0.9 High Similarity NPC250846
0.9 High Similarity NPC264850
0.9 High Similarity NPC42549
0.8994 High Similarity NPC318805
0.8994 High Similarity NPC41122
0.8962 High Similarity NPC475654
0.8941 High Similarity NPC24465
0.8901 High Similarity NPC234318
0.8895 High Similarity NPC204908
0.8895 High Similarity NPC83198
0.8882 High Similarity NPC475393
0.887 High Similarity NPC73492
0.887 High Similarity NPC299990
0.8757 High Similarity NPC474507
0.8743 High Similarity NPC152680
0.8743 High Similarity NPC190783
0.8743 High Similarity NPC232386
0.8736 High Similarity NPC109925
0.8721 High Similarity NPC284183
0.8721 High Similarity NPC4138
0.8721 High Similarity NPC121275
0.8717 High Similarity NPC254581
0.8715 High Similarity NPC302275
0.8708 High Similarity NPC230276
0.8708 High Similarity NPC257269
0.8667 High Similarity NPC249996
0.8652 High Similarity NPC119068
0.8652 High Similarity NPC40496
0.8644 High Similarity NPC148709
0.8644 High Similarity NPC476577
0.8644 High Similarity NPC173416
0.8603 High Similarity NPC195538
0.8588 High Similarity NPC247639
0.8588 High Similarity NPC25084
0.8579 High Similarity NPC473716
0.8579 High Similarity NPC475597
0.8556 High Similarity NPC476202
0.8529 High Similarity NPC39701
0.8529 High Similarity NPC207757
0.8529 High Similarity NPC172765
0.8529 High Similarity NPC184026
0.8529 High Similarity NPC189266
0.8529 High Similarity NPC295691
0.8529 High Similarity NPC5238
0.8529 High Similarity NPC193949
0.8529 High Similarity NPC276588
0.8529 High Similarity NPC2413
0.8529 High Similarity NPC278799
0.8529 High Similarity NPC127674
0.8529 High Similarity NPC204828
0.8529 High Similarity NPC110416
0.8529 High Similarity NPC249797
0.8529 High Similarity NPC469817
0.8529 High Similarity NPC54379
0.8516 High Similarity NPC14507
0.8516 High Similarity NPC47077
0.8475 Intermediate Similarity NPC239775
0.8471 Intermediate Similarity NPC2295
0.8471 Intermediate Similarity NPC477564
0.8457 Intermediate Similarity NPC223077
0.8457 Intermediate Similarity NPC56887
0.8457 Intermediate Similarity NPC193853
0.8427 Intermediate Similarity NPC66341
0.8427 Intermediate Similarity NPC192135
0.8427 Intermediate Similarity NPC477020
0.8418 Intermediate Similarity NPC477562
0.8418 Intermediate Similarity NPC168753
0.8418 Intermediate Similarity NPC69712
0.8418 Intermediate Similarity NPC118274
0.8418 Intermediate Similarity NPC26240
0.84 Intermediate Similarity NPC209377
0.8371 Intermediate Similarity NPC10871
0.837 Intermediate Similarity NPC476576
0.837 Intermediate Similarity NPC186546
0.8353 Intermediate Similarity NPC277669
0.8353 Intermediate Similarity NPC76213
0.8314 Intermediate Similarity NPC187022
0.8314 Intermediate Similarity NPC80129
0.8305 Intermediate Similarity NPC204947
0.8294 Intermediate Similarity NPC88249
0.8294 Intermediate Similarity NPC192768
0.8294 Intermediate Similarity NPC97221
0.8294 Intermediate Similarity NPC151895
0.8294 Intermediate Similarity NPC220858
0.8286 Intermediate Similarity NPC60186
0.8249 Intermediate Similarity NPC476573
0.8249 Intermediate Similarity NPC35627
0.8249 Intermediate Similarity NPC81247
0.8241 Intermediate Similarity NPC82056
0.8235 Intermediate Similarity NPC207824
0.8235 Intermediate Similarity NPC476565
0.8235 Intermediate Similarity NPC103379
0.8235 Intermediate Similarity NPC477565
0.8235 Intermediate Similarity NPC60538
0.8232 Intermediate Similarity NPC38964
0.8229 Intermediate Similarity NPC235143
0.8229 Intermediate Similarity NPC119649
0.8229 Intermediate Similarity NPC271388
0.8229 Intermediate Similarity NPC205255
0.8229 Intermediate Similarity NPC230956
0.8216 Intermediate Similarity NPC57036
0.8202 Intermediate Similarity NPC474931
0.8202 Intermediate Similarity NPC81218
0.8202 Intermediate Similarity NPC158376
0.8202 Intermediate Similarity NPC117188
0.8202 Intermediate Similarity NPC205421
0.8202 Intermediate Similarity NPC306555
0.8202 Intermediate Similarity NPC145832
0.8202 Intermediate Similarity NPC12053
0.8192 Intermediate Similarity NPC212794
0.8192 Intermediate Similarity NPC253043
0.8192 Intermediate Similarity NPC276944
0.8192 Intermediate Similarity NPC238530
0.8192 Intermediate Similarity NPC13504
0.8192 Intermediate Similarity NPC96603
0.8192 Intermediate Similarity NPC232514
0.8192 Intermediate Similarity NPC136508
0.8192 Intermediate Similarity NPC477563
0.8192 Intermediate Similarity NPC306843
0.8192 Intermediate Similarity NPC78222
0.8192 Intermediate Similarity NPC196447

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC60295 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9647 High Similarity NPD8053 Approved
0.9647 High Similarity NPD8054 Approved
0.9235 High Similarity NPD8251 Approved
0.9235 High Similarity NPD8099 Discontinued
0.9235 High Similarity NPD8252 Approved
0.9181 High Similarity NPD8156 Discontinued
0.8652 High Similarity NPD8453 Clinical (unspecified phase)
0.8314 Intermediate Similarity NPD7298 Approved
0.8307 Intermediate Similarity NPD8095 Phase 1
0.8118 Intermediate Similarity NPD4584 Approved
0.8068 Intermediate Similarity NPD6788 Approved
0.7926 Intermediate Similarity NPD7906 Approved
0.7907 Intermediate Similarity NPD1424 Approved
0.7841 Intermediate Similarity NPD4773 Phase 2
0.7841 Intermediate Similarity NPD4772 Phase 2
0.7816 Intermediate Similarity NPD6030 Approved
0.7816 Intermediate Similarity NPD6031 Approved
0.7772 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD4664 Clinical (unspecified phase)
0.7753 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7747 Intermediate Similarity NPD6071 Discontinued
0.7722 Intermediate Similarity NPD7831 Phase 2
0.7722 Intermediate Similarity NPD7833 Phase 2
0.7722 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7713 Intermediate Similarity NPD7312 Approved
0.7713 Intermediate Similarity NPD7313 Approved
0.7713 Intermediate Similarity NPD7310 Approved
0.7713 Intermediate Similarity NPD7311 Approved
0.7688 Intermediate Similarity NPD3845 Phase 1
0.7672 Intermediate Similarity NPD7309 Approved
0.7667 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.7663 Intermediate Similarity NPD27 Approved
0.7663 Intermediate Similarity NPD2489 Approved
0.765 Intermediate Similarity NPD3051 Approved
0.7627 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD4577 Approved
0.7619 Intermediate Similarity NPD4578 Approved
0.7609 Intermediate Similarity NPD2969 Approved
0.7609 Intermediate Similarity NPD2970 Approved
0.76 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD7447 Phase 1
0.7596 Intermediate Similarity NPD6107 Approved
0.7592 Intermediate Similarity NPD4663 Approved
0.7544 Intermediate Similarity NPD1632 Clinical (unspecified phase)
0.7543 Intermediate Similarity NPD7598 Phase 2
0.7541 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.7523 Intermediate Similarity NPD8152 Approved
0.7523 Intermediate Similarity NPD8153 Approved
0.7514 Intermediate Similarity NPD2563 Approved
0.7514 Intermediate Similarity NPD2560 Approved
0.7486 Intermediate Similarity NPD2422 Clinical (unspecified phase)
0.7474 Intermediate Similarity NPD7549 Discontinued
0.7459 Intermediate Similarity NPD4010 Discontinued
0.7457 Intermediate Similarity NPD7045 Clinical (unspecified phase)
0.7443 Intermediate Similarity NPD7213 Phase 3
0.7443 Intermediate Similarity NPD7212 Phase 2
0.7396 Intermediate Similarity NPD6851 Approved
0.7396 Intermediate Similarity NPD6853 Approved
0.7384 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7384 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.738 Intermediate Similarity NPD2898 Approved
0.7379 Intermediate Similarity NPD7827 Phase 1
0.7368 Intermediate Similarity NPD6297 Approved
0.7354 Intermediate Similarity NPD6042 Phase 2
0.7354 Intermediate Similarity NPD42 Phase 2
0.7345 Intermediate Similarity NPD2420 Approved
0.7345 Intermediate Similarity NPD2421 Approved
0.7337 Intermediate Similarity NPD4055 Discovery
0.733 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7314 Intermediate Similarity NPD4162 Approved
0.7314 Intermediate Similarity NPD3060 Approved
0.73 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD4678 Approved
0.7293 Intermediate Similarity NPD4675 Approved
0.7288 Intermediate Similarity NPD7124 Phase 2
0.7268 Intermediate Similarity NPD2977 Approved
0.7268 Intermediate Similarity NPD4585 Approved
0.7268 Intermediate Similarity NPD2978 Approved
0.7258 Intermediate Similarity NPD5677 Discontinued
0.7253 Intermediate Similarity NPD6072 Discontinued
0.7238 Intermediate Similarity NPD4017 Approved
0.7232 Intermediate Similarity NPD5241 Discontinued
0.7232 Intermediate Similarity NPD2677 Approved
0.7232 Intermediate Similarity NPD5160 Discontinued
0.7228 Intermediate Similarity NPD3450 Approved
0.7228 Intermediate Similarity NPD2493 Approved
0.7228 Intermediate Similarity NPD3452 Approved
0.7228 Intermediate Similarity NPD2494 Approved
0.7225 Intermediate Similarity NPD7479 Phase 2
0.7222 Intermediate Similarity NPD3640 Phase 3
0.7222 Intermediate Similarity NPD3641 Approved
0.7222 Intermediate Similarity NPD3639 Approved
0.7219 Intermediate Similarity NPD7802 Discontinued
0.7208 Intermediate Similarity NPD2490 Approved
0.7208 Intermediate Similarity NPD2488 Approved
0.7207 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7196 Intermediate Similarity NPD4481 Phase 3
0.7181 Intermediate Similarity NPD4166 Phase 2
0.7174 Intermediate Similarity NPD7046 Clinical (unspecified phase)
0.7173 Intermediate Similarity NPD4873 Discontinued
0.7167 Intermediate Similarity NPD3647 Clinical (unspecified phase)
0.7166 Intermediate Similarity NPD4666 Phase 3
0.715 Intermediate Similarity NPD6997 Phase 2
0.7143 Intermediate Similarity NPD4005 Discontinued
0.7128 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7127 Intermediate Similarity NPD2122 Discontinued
0.7127 Intermediate Similarity NPD5976 Discontinued
0.7122 Intermediate Similarity NPD4582 Approved
0.7122 Intermediate Similarity NPD4040 Phase 1
0.7122 Intermediate Similarity NPD4583 Approved
0.712 Intermediate Similarity NPD5940 Clinical (unspecified phase)
0.7112 Intermediate Similarity NPD5709 Phase 3
0.7109 Intermediate Similarity NPD7047 Phase 3
0.7093 Intermediate Similarity NPD4474 Approved
0.7093 Intermediate Similarity NPD4475 Approved
0.7091 Intermediate Similarity NPD6723 Discontinued
0.7081 Intermediate Similarity NPD5773 Approved
0.7081 Intermediate Similarity NPD5772 Approved
0.7079 Intermediate Similarity NPD6748 Discontinued
0.7073 Intermediate Similarity NPD4002 Approved
0.7073 Intermediate Similarity NPD4004 Approved
0.7059 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7056 Intermediate Similarity NPD1774 Approved
0.7056 Intermediate Similarity NPD3124 Discontinued
0.7049 Intermediate Similarity NPD6523 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD6618 Phase 2
0.7035 Intermediate Similarity NPD5718 Phase 2
0.703 Intermediate Similarity NPD2973 Approved
0.703 Intermediate Similarity NPD2975 Approved
0.703 Intermediate Similarity NPD2974 Approved
0.7029 Intermediate Similarity NPD2200 Suspended
0.7027 Intermediate Similarity NPD3382 Approved
0.7027 Intermediate Similarity NPD3383 Approved
0.7027 Intermediate Similarity NPD3384 Approved
0.7027 Intermediate Similarity NPD5722 Discontinued
0.7024 Intermediate Similarity NPD5005 Approved
0.7024 Intermediate Similarity NPD5006 Approved
0.7022 Intermediate Similarity NPD5177 Phase 3
0.7018 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7017 Intermediate Similarity NPD4123 Phase 3
0.701 Intermediate Similarity NPD6996 Clinical (unspecified phase)
0.701 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.6995 Remote Similarity NPD5313 Approved
0.6995 Remote Similarity NPD5312 Approved
0.6989 Remote Similarity NPD2154 Approved
0.6989 Remote Similarity NPD2155 Approved
0.6989 Remote Similarity NPD2156 Approved
0.6983 Remote Similarity NPD3977 Clinical (unspecified phase)
0.6983 Remote Similarity NPD7466 Approved
0.6978 Remote Similarity NPD7527 Clinical (unspecified phase)
0.6978 Remote Similarity NPD7526 Approved
0.6978 Remote Similarity NPD5261 Clinical (unspecified phase)
0.6978 Remote Similarity NPD52 Approved
0.6978 Remote Similarity NPD6090 Discontinued
0.6966 Remote Similarity NPD7153 Discontinued
0.6961 Remote Similarity NPD6087 Phase 1
0.6959 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6957 Remote Similarity NPD8158 Clinical (unspecified phase)
0.6954 Remote Similarity NPD1613 Approved
0.6954 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6941 Remote Similarity NPD3053 Approved
0.6941 Remote Similarity NPD3055 Approved
0.6939 Remote Similarity NPD7132 Clinical (unspecified phase)
0.6935 Remote Similarity NPD7945 Clinical (unspecified phase)
0.6935 Remote Similarity NPD5720 Discontinued
0.6927 Remote Similarity NPD5061 Approved
0.6927 Remote Similarity NPD4580 Approved
0.6927 Remote Similarity NPD5062 Approved
0.6919 Remote Similarity NPD4908 Phase 1
0.6906 Remote Similarity NPD3122 Phase 3
0.6904 Remote Similarity NPD2971 Approved
0.6904 Remote Similarity NPD2968 Approved
0.6904 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6902 Remote Similarity NPD3687 Approved
0.6902 Remote Similarity NPD3686 Approved
0.69 Remote Similarity NPD6377 Clinical (unspecified phase)
0.69 Remote Similarity NPD2845 Phase 2
0.69 Remote Similarity NPD2843 Phase 2
0.6891 Remote Similarity NPD5602 Clinical (unspecified phase)
0.6888 Remote Similarity NPD7039 Approved
0.6888 Remote Similarity NPD7038 Approved
0.6882 Remote Similarity NPD5311 Approved
0.6882 Remote Similarity NPD5310 Approved
0.6875 Remote Similarity NPD2568 Approved
0.6875 Remote Similarity NPD817 Approved
0.6875 Remote Similarity NPD3052 Approved
0.6875 Remote Similarity NPD823 Approved
0.6875 Remote Similarity NPD5314 Approved
0.6875 Remote Similarity NPD3054 Approved
0.6866 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6866 Remote Similarity NPD5525 Clinical (unspecified phase)
0.6863 Remote Similarity NPD6284 Clinical (unspecified phase)
0.6863 Remote Similarity NPD6621 Clinical (unspecified phase)
0.6863 Remote Similarity NPD4605 Approved
0.6863 Remote Similarity NPD4604 Approved
0.6856 Remote Similarity NPD7493 Clinical (unspecified phase)
0.6853 Remote Similarity NPD3936 Clinical (unspecified phase)
0.6852 Remote Similarity NPD8318 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data